Funding · Sep 3, 2026 · as investor
AIPher, an AI4S drug discovery startup incubated by Tsinghua AIR, raises angel round of over RMB 100 million
An angel round of over RMB 100 million ($14M) has gone to AIPher, a Tsinghua AIR-incubated AI drug discovery startup. Xianghe Capital led, with Xinglian Capital among other backers. The company says the money will support its DrugCLIP foundation model and PharmAgents agent platform, as well as internal pipelines. AIPher says it already works with more than five pharmaceutical and biotech partners, and its most advanced program is in pre-PCC.
Original sources (Chinese)
清华AIR孵化，AI4S企业「艾斐智药」获亿元级天使轮融资｜36氪首发